Bibliographic Info
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Very low
The preferred first-line ARV regimen for infants and children less than 2 years of age who have been exposed to nevirapine (NVP) and are taking a rifampicin-containing regimen for TB is a triple nucleoside reverse transcriptase inhibitor (NRTI) regimen.